Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study

FQ Pires, T Angelo, JKR Silva, LCL Sá-Barreto… - … of pharmaceutical and …, 2017 - Elsevier
The objective of this work was to access thymol-excipient compatibility using an alternative
protocol of mixture design subsidizing the development of nanostructures lipid carriers …
被引用次数：43 相关文章
[PDF] researchgate.net

[PDF][PDF] Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study

FQ Pires, T Angelo, JKR Silva… - Journal of …, 2017 - researchgate.net
abstract The objective of this work was to access thymol-excipient compatibility using an
alternative protocol of mixture design subsidizing the development of nanostructures lipid …

Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study

FQ Pires, T Angelo, JKR Silva… - Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
The objective of this work was to access thymol-excipient compatibility using an alternative
protocol of mixture design subsidizing the development of nanostructures lipid carriers …

Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study.

FQ Pires, T Angelo, JK Silva, LC Sá-Barreto… - Journal of …, 2017 - europepmc.org
The objective of this work was to access thymol-excipient compatibility using an alternative
protocol of mixture design subsidizing the development of nanostructures lipid carriers …

Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study

FQ Pires, T Angelo, JK Silva, LC Sá-Barreto… - … of Pharmaceutical and …, 2017 - hero.epa.gov
The objective of this work was to access thymol-excipient compatibility using an alternative
protocol of mixture design subsidizing the development of nanostructures lipid carriers …